Mark Pinese

Cited by

	All	Since 2016
Citations	7783	6395
h-index	30	26
i10-index	40	37

1700

850

425

1275

200920102011201220132014201520162017201820192020202122 41 58 97 248 341 506 803 1032 1247 1302 1618 376

Co-authors

Andrew BiankinRegius Professor of Surgery, University of GlasgowVerified email at glasgow.ac.uk
Mark James CowleyComputational Biology Group leader, Children's Cancer Institute and Associate Professor at UNSWVerified email at ccia.org.au
David K. ChangAssociate Professor of Surgery, University of GlasgowVerified email at glasgow.ac.uk
James KenchLocal Pathology Director, Royal Prince Alfred Hospital and Clinical Professor, University of SydneyVerified email at health.nsw.gov.au
Sandra O'TooleClinical Professor Sydney University and Staff Specialist Tissue Pathology Royal Prince Alfred HospitalVerified email at garvan.org.au
Nicola WaddellQIMR Berghofer Medical Research InstituteVerified email at qimrberghofer.edu.au
Prof. Sean M. GrimmondThe University of Melbourne Centre for Cancer ResearchVerified email at unimelb.edu.au
john v pearsonQIMR Berghofer MRIVerified email at qimrberghofer.edu.au
Anthony GillProfessor of Surgical Pathology, Sydney UniversityVerified email at med.usyd.edu.au
ormandy cjVerified email at garvan.org.au
Assoc Professor Ewan MillarNSW Health Pathology,St George Hospital; UNSW Sydney & WSUVerified email at health.nsw.gov.au
Alexander SwarbrickLaboratory Head, Garvan Institute of Medical Research | Co-Head, Breast Translational OncologyVerified email at garvan.org.au
C. Elizabeth CaldonGarvan Institute of Medical Research, AustraliaVerified email at garvan.org.au
Venessa ChinGarvan Institute of Medical ResearchVerified email at garvan.org.au
Adnan NagrialUniversity of SydneyVerified email at health.nsw.gov.au
lorraine chantrillSenior Staff Specialist and Director Medical Oncology; Illawarra Shoalhaven Local Health DistrictVerified email at health.nsw.gov.au
Ruby CY LinWestmead Institute for Medical ResearchVerified email at unsw.edu.au
David R. CroucherGarvan Institute of Medical ResearchVerified email at garvan.org.au
Nigel B JamiesonClinical Senior Lecturer and Consultant Pancreatic Surgeon, Glasgow UniversityVerified email at glasgow.ac.uk
PETER BAILEYSenior Lecturer University of GlasgowVerified email at glasgow.ac.uk

Mark Pinese

Children's Cancer Institute

Verified email at ccia.org.au

Genomics Cancer Biostatistics Bioinformatics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015	1622	2015
Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016	1607	2016
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012	1607	2012
Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017	423	2017
PINA v2. 0: mining interactome modules MJ Cowley, M Pinese, KS Kassahn, N Waddell, JV Pearson, ... Nucleic acids research 40 (D1), D862-D865, 2012	310	2012
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells F Hochgräfe, L Zhang, SA O'Toole, BC Browne, M Pinese, AP Cubas, ... Cancer research 70 (22), 9391-9401, 2010	178	2010
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ... EMBO molecular medicine 7 (8), 1063-1076, 2015	158	2015
Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling K Nones, N Waddell, S Song, AM Patch, D Miller, A Johns, J Wu, ... International journal of cancer 135 (5), 1110-1118, 2014	158	2014
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ... Science translational medicine 9 (384), 2017	135	2017
Hypermutation in pancreatic cancer JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ... Gastroenterology 152 (1), 68-74. e2, 2017	124	2017
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater DK Chang, NB Jamieson, AL Johns, CJ Scarlett, M Pajic, A Chou, ... Journal of clinical oncology 31 (10), 1348-1356, 2013	123	2013
Identification of functional networks of estrogen-and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer EA Musgrove, CM Sergio, S Loi, CK Inman, LR Anderson, MC Alles, ... PloS one 3 (8), e2987, 2008	108	2008
Clinical and molecular characterization of HER2 amplified-pancreatic cancer A Chou, N Waddell, MJ Cowley, AJ Gill, DK Chang, AM Patch, K Nones, ... Genome medicine 5 (8), 1-11, 2013	93	2013
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer AV Biankin, JG Kench, EK Colvin, D Segara, CJ Scarlett, NQ Nguyen, ... Gastroenterology 137 (2), 558-568. e11, 2009	84	2009
The effect of resveratrol on a cell model of human aging M Stefani, MA Markus, RCY Lin, M Pinese, IW Dawes, BJ Morris Annals of the New York Academy of Sciences 1114 (1), 407-418, 2007	81	2007
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles S Song, K Nones, D Miller, I Harliwong, KS Kassahn, M Pinese, M Pajic, ... PloS one 7 (9), e45835, 2012	75	2012
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype SJ Zardawi, I Zardawi, CM McNeil, EKA Millar, D McLeod, AL Morey, ... Histopathology 56 (3), 286-296, 2010	74	2010
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer A Chou, D Froio, AM Nagrial, A Parkin, KJ Murphy, VT Chin, D Wohl, ... Gut 67 (12), 2142-2155, 2018	59	2018
Clinical and pathologic features of familial pancreatic cancer JL Humphris, AL Johns, SH Simpson, MJ Cowley, M Pajic, DK Chang, ... Cancer 120 (23), 3669-3675, 2014	57	2014
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction CJ Scarlett, EK Colvin, M Pinese, DK Chang, AL Morey, EA Musgrove, ... PloS one 6 (10), e26088, 2011	57	2011

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors